Health Sciences Group Begins Public Filings Reporting With the OTC Disclosure Service

  Health Sciences Group Inc. (PINKSHEETS: HESG) announced today that it has subscribed to the OTC Disclosure Service to provide regular disclosures and transparency to investors. Regular public disclosure and financial reporting enhances the Company's credibility among both industry peers and public investors.

The Company will timely file current disclosures and financial information for 2012. Concurrent with its subscription to the OTC Disclosure Service, the Company has brought its filings with State of Florida current and made the required filings with the Securities Exchange Commissions.

Investors can access the Company's public filings at www.otcmarkets.com.

The Company expects to make further announcements regarding its newly revised business.

About Health Sciences Group Inc.

Health Sciences Group, Inc. is an investment technology portfolio company that acquires nascent health sciences technology and related innovations, inventions and IP assets to enhance their growth and development. The company builds revenues and asset value through a model of continuous growth, income from or sale of its portfolio holdings, and technology licensing or distribution agreements.

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control. Some of these factors include the ability of the company to raise sufficient capital, attract qualified management, attract new customers and effectively compete against similar companies.

Health Sciences Group, Inc. Investor Relations 949-209-8843 [e-mail]